Journal: Neoplasia (New York, N.Y.)
Article Title: Identification of BET inhibitors (BETi) against solitary fibrous tumor (SFT) through high-throughput screening (HTS)
doi: 10.1016/j.neo.2025.101244
Figure Lengend Snippet: Identification of Mivebresib as an efficient and specific anti-SFT (Solitary Fibrous Tumor) agent. (a) Secondary high-throughput screening (HTS) was performed using the Moffitt-ns and immortalized lung fibroblast cells. The CTG effects of both cell lines under all four doses were plotted. The green line indicated the differences in suppression effects between Moffitt-ns and Lf > 40 %. The blue line indicated that the suppression effects at the highest dose should be > 50 % in Moffitt-ns cells. 3 compounds were shown (Mivebresib: green, Zinc Pyrithione: red, and TAK-901: yellow). (b-f) Confirmatory MTS assays were performed in two primary SFT cells (INT-SFT and IEC139) and two control LMS cells (SKUT-1 and CP0024). Only Mivebresib showed efficient and selective cell proliferation-suppressing effects in SFT cells. (): INT-SFT; (): IEC139; (): SKUT-1; (): CP0024.
Article Snippet: The hTERT-immortalized human lung fibroblast cell line (Lf) was acquired from the American Type Culture Collection (catalog number: CRL-4058) and maintained at 37 °C, 100 % humidity, and 5 % CO 2 .
Techniques: High Throughput Screening Assay, Control